Isofol Medical AB (publ) (STO: ISOFOL)
Sweden
· Delayed Price · Currency is SEK 2.900
-0.290 (-9.09%)
Aug 30, 2024, 5:29 PM CET
Isofol Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 0.08 | 0.21 | 2.19 | 3.59 | 3.43 | 1.81 | Upgrade
|
| Revenue | 0.08 | 0.21 | 2.19 | 3.59 | 3.43 | 1.81 | Upgrade
|
| Revenue Growth (YoY) | -88.25% | -90.28% | -38.90% | 4.46% | 89.25% | -71.65% | Upgrade
|
| Cost of Revenue | 0.27 | 0.48 | 2.26 | 3.83 | 3.7 | 2.07 | Upgrade
|
| Gross Profit | -0.19 | -0.27 | -0.07 | -0.24 | -0.26 | -0.26 | Upgrade
|
| Selling, General & Admin | 11.97 | 7.3 | 7.34 | 5.15 | 4.28 | 3.99 | Upgrade
|
| Other Operating Expenses | -0 | -0 | - | - | - | - | Upgrade
|
| Operating Expenses | 11.97 | 7.29 | 7.34 | 5.15 | 4.32 | 4.31 | Upgrade
|
| Operating Income | -12.16 | -7.56 | -7.41 | -5.4 | -4.58 | -4.56 | Upgrade
|
| Interest Expense | -0.29 | -0.26 | -0.18 | -0.18 | -0.17 | -0.56 | Upgrade
|
| Interest & Investment Income | 0.42 | 0.42 | 0 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -12.03 | -7.4 | -7.59 | -5.57 | -4.75 | -5.12 | Upgrade
|
| Pretax Income | -12.03 | -7.4 | -7.59 | -5.57 | -4.75 | -5.12 | Upgrade
|
| Income Tax Expense | - | -0.13 | - | - | - | - | Upgrade
|
| Net Income | -12.03 | -7.28 | -7.59 | -5.57 | -4.75 | -5.12 | Upgrade
|
| Net Income to Common | -12.03 | -7.28 | -7.59 | -5.57 | -4.75 | -5.12 | Upgrade
|
| Shares Outstanding (Basic) | 40 | 40 | 29 | 29 | 27 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 40 | 41 | 29 | 30 | 27 | 23 | Upgrade
|
| Shares Change (YoY) | 14.35% | 40.33% | -1.82% | 10.22% | 16.61% | 0.37% | Upgrade
|
| EPS (Basic) | -0.30 | -0.18 | -0.26 | -0.19 | -0.18 | -0.22 | Upgrade
|
| EPS (Diluted) | -0.31 | -0.18 | -0.26 | -0.19 | -0.18 | -0.22 | Upgrade
|
| Free Cash Flow | -15.59 | -20.05 | -6.03 | -3.61 | -7.32 | -3.53 | Upgrade
|
| Free Cash Flow Per Share | -0.39 | -0.49 | -0.21 | -0.12 | -0.27 | -0.15 | Upgrade
|
| Gross Margin | -244.87% | -126.76% | -3.29% | -6.75% | -7.69% | -14.06% | Upgrade
|
| Operating Margin | -15592.31% | -3550.70% | -338.06% | -150.45% | -133.47% | -251.38% | Upgrade
|
| Profit Margin | -15424.36% | -3416.43% | -346.37% | -155.38% | -138.42% | -282.30% | Upgrade
|
| Free Cash Flow Margin | -19982.05% | -9413.62% | -275.40% | -100.59% | -213.22% | -194.49% | Upgrade
|
| EBITDA | - | - | - | -5.36 | -4.54 | -4.24 | Upgrade
|
| EBITDA Margin | - | - | - | -149.36% | -132.33% | -233.74% | Upgrade
|
| D&A For EBITDA | - | - | - | 0.04 | 0.04 | 0.32 | Upgrade
|
| EBIT | -12.16 | -7.56 | -7.41 | -5.4 | -4.58 | -4.56 | Upgrade
|
| EBIT Margin | - | - | - | -150.45% | -133.47% | -251.38% | Upgrade
|
| Revenue as Reported | 0.22 | 0.22 | 2.19 | 3.59 | 3.43 | 1.81 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.